With the analysis among 989 patents, we discovered top 210 key players by total patent application. Celgene Corp., AbbVie Biotherapeutics, Inc., Unigen Co., Ltd. are dominant in this area. They take 11.63% of the total patent filing.
New Jersey, United States
Patent: 40
Illinois, United States
Patent: 38
Gyeonggi-do, South Korea
Patent: 37
Louisiana, United States
Patent: 26
California, United States
Patent: 24
California, United States
Patent: 18
Jiangsu Sheng, China
Patent: 16
With the analysis among 6 patents, we discovered top 3 start-ups by total patent application.
With the analysis among related 34 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Chung-Ang University Industry Academic Cooperation Foundation, NeoPharm, Inc., Reata Pharmaceuticals, Inc. take 17.65% of patent filing during this period.
Illinois, United States
Patent: 2
Texas, United States
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
Pennsylvania, United States
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
Jiangsu Sheng, China
Patent: 1
With the analysis among related 34 patents in last 5 years, we discover 10 new entrants. Chung-Ang University Industry Academic Cooperation Foundation, Korea University Reserch & Business Foundation, NeoPharm, Inc. are the most active new entrants in this area.
Illinois, United States
Patent: 2
Nordrhein-Westfalen, Germany
Patent: 2
Beijing Shi, China
Patent: 1
Anhui Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among 267 patents, we discovered top 45 universities and scientific research institutions by total patent application. Massachusetts Institute of Technology, The Scripps Research Institute, University of Miami are dominant in this area. They take 22.10% of the total patent filing.
Massachusetts, United States
Patent: 26
California, United States
Patent: 16
Texas, United States
Patent: 10
Mazowieckie, Poland
Patent: 8
Guangdong Sheng, China
Patent: 4
North Carolina, United States
Patent: 3